Proof-of-concept for quantitative measurement of capillary refilling time

CRT

Proof-of-concept for quantitative measurement of capillary refilling time |

Medical Need

Based on experimental and clinical data, it was shown that a disturbance of the microcirculation contributes significantly to the development of organ dysfunctions and is associated with increased lethality. A better understanding of the relationship between macro- and microcirculation is a prerequisite for the establishment of therapy strategies that include parameters of microcirculation. A widely used clinical assessment of microcirculation, the capillary refill time, is a building block for therapy decisions. All measurement methods used so far are strongly dependent on the examiner. Thus, the intra-individual and inter-individual comparability of these procedures is very limited. Therefore, an objective quantitative measurement of these parameters is urgently required.

Project team members |

Clinician |

TU Dresden, Faculty of Medicine
University Hospital Dresden, Department for Anesthesia and Intensive Care Medicine

High-tech |

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP
Division Microdisplays & Sensors

Abstract |

This project concerns a highly innovative topic that we consider to benefit emergency and intensive care as well as commercial exploitation within a few years perspective. It targets the in-situ evaluation of microcirculation as an indirect means of patient perfusion. Therefore, we will prototype an optoelectronic testing device, based on bi-directional OLED micro-display technology of Fraunhofer FEP. The general device design and target application has been submitted for patent protection. A team of a tech-savvy clinician scientist and high-tech talent will perform proof-of-concept work In close cooperation with Fraunhofer FEP, CRT will construct a first prototype that meets the minimum requirements. As a result, this device should already reach manageable dimensions within its technical limitations in order to enable clinical testing.

We will provide the animal experimental study in close cooperation with the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). In clinical testing, the intra-individual and inter-individual measuring accuracy of the device will first be evaluated in comparison to the conventional investigator-dependent method. In particular, volunteers with different skin types will be tested. Subsequently, we will examine the clinical applicability in patients.

Skip to content
This site is registered on wpml.org as a development site.